Brandon Couillard
Stock Analyst at Wells Fargo
(4.62)
# 213
Out of 5,055 analysts
157
Total ratings
65.98%
Success rate
17.68%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,200 → $1,400 | $1,388.96 | +0.79% | 6 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Equal-Weight | $175 → $190 | $206.04 | -7.78% | 2 | Nov 7, 2025 | |
| TECH Bio-Techne | Maintains: Overweight | $59 → $70 | $58.61 | +19.43% | 2 | Nov 6, 2025 | |
| WAT Waters | Maintains: Equal-Weight | $315 → $385 | $377.98 | +1.86% | 6 | Nov 5, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $48 | $41.77 | +14.92% | 6 | Nov 5, 2025 | |
| MYGN Myriad Genetics | Maintains: Equal-Weight | $6 → $6.5 | $6.66 | -2.40% | 3 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $68 → $85 | $67.15 | +26.58% | 17 | Nov 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $95 → $140 | $129.55 | +8.07% | 5 | Nov 4, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $265 → $340 | $304.06 | +11.82% | 13 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $265 → $340 | $310.70 | +9.43% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 → $635 | $567.16 | +11.96% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $205 → $230 | $220.44 | +4.34% | 4 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $72 | $96.48 | -25.37% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $144.52 | +3.79% | 24 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $19 → $14 | $15.51 | -9.74% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $100 → $67 | $71.62 | -6.45% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $10.88 | +47.06% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $175 | $149.00 | +17.45% | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $91.06 | +12.01% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $132.61 | +96.06% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $71.25 | +12.28% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $3.34 | +199.40% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $19.11 | +20.36% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.90 | +584.21% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.25 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.57 | +600.64% | 2 | Oct 13, 2017 |
Mettler-Toledo International
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $1,200 → $1,400
Current: $1,388.96
Upside: +0.79%
Natera
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $175 → $190
Current: $206.04
Upside: -7.78%
Bio-Techne
Nov 6, 2025
Maintains: Overweight
Price Target: $59 → $70
Current: $58.61
Upside: +19.43%
Waters
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $315 → $385
Current: $377.98
Upside: +1.86%
Bruker
Nov 5, 2025
Maintains: Overweight
Price Target: $50 → $48
Current: $41.77
Upside: +14.92%
Myriad Genetics
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $6.66
Upside: -2.40%
Exact Sciences
Nov 5, 2025
Maintains: Overweight
Price Target: $68 → $85
Current: $67.15
Upside: +26.58%
GeneDx Holdings
Nov 4, 2025
Maintains: Equal-Weight
Price Target: $95 → $140
Current: $129.55
Upside: +8.07%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $304.06
Upside: +11.82%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $310.70
Upside: +9.43%
Oct 23, 2025
Maintains: Overweight
Price Target: $565 → $635
Current: $567.16
Upside: +11.96%
Oct 23, 2025
Maintains: Equal-Weight
Price Target: $205 → $230
Current: $220.44
Upside: +4.34%
Sep 22, 2025
Initiates: Overweight
Price Target: $72
Current: $96.48
Upside: -25.37%
Sep 15, 2025
Maintains: Overweight
Price Target: $140 → $150
Current: $144.52
Upside: +3.79%
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $19 → $14
Current: $15.51
Upside: -9.74%
Aug 8, 2025
Upgrades: Equal-Weight
Price Target: $100 → $67
Current: $71.62
Upside: -6.45%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $10.88
Upside: +47.06%
Jul 30, 2025
Maintains: Overweight
Price Target: $180 → $175
Current: $149.00
Upside: +17.45%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $91.06
Upside: +12.01%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $132.61
Upside: +96.06%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $71.25
Upside: +12.28%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $3.34
Upside: +199.40%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $19.11
Upside: +20.36%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.90
Upside: +584.21%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.25
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.57
Upside: +600.64%